Sparfloxacin
Records for this ingredient, by country (identity only).
ATC J01MA · 2 markets · 44 records
CN 38 records · 5 shown of 5
- 100 mgtablet力贝尔司帕沙星星特、朗瑞、森澳欣、海正立特、Manufacturer: 乐普药业股份有限公司、Manufacturer: 唐山隆康药业有限公司、Manufacturer: 大同五洲通制药有限责任公司
- 100 mgcapsule森澳欣司帕沙星海正立特、Manufacturer: 广东彼迪药业有限公司、Manufacturer: 澳美制药(海南)有限公司、Manufacturer: 青州尧王制药有限公司
- 200 mgtablet朗瑞司帕沙星Manufacturer: 大同五洲通制药有限责任公司
- 150 mgtabletManufacturer: 大同五洲通制药有限责任公司 ×6
- 100 mgpowderManufacturer: 浙江海正药业股份有限公司 ×2
JP 6 records · 4 shown of 4
- 100 mgtabletシプロキサン錠200mg
- 200 mgtabletシプロキサン錠200mg
- 400 mg/200 mLinjectionシプロキサン注400mgシプロフロキサシン点滴静注液400mg「ニプロ」
- 200 mg/100 mLinjectionシプロキサン注400mgシプロフロキサシン点滴静注液200mg「NP」
Also called: 乳酸司帕沙星 nickname
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.